Patents by Inventor Valentina Albarani

Valentina Albarani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations involving solvent/detergent-treated plasma (S/D plasma) and uses thereof
    Patent number: 11458166
    Abstract: The invention concerns pharmaceutical formulations comprising solvent/detergent (S/D)-treated plasma and a glycosaminoglycan such as hyaluronic acid, and their use for treating diseases, particularly musculoskeletal diseases.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: October 4, 2022
    Assignees: Bone Therapeutics S.A, Enrico Bastianelli SPRL
    Inventors: Enrico Bastianelli, Valentina Albarani
  • Formulations Involving Solvent/Detergent-Treated Plasma (S/D Plasma) and Uses Thereof
    Publication number: 20150238528
    Abstract: The invention concerns pharmaceutical formulations comprising solvent/detergent (S/D)-treated plasma and a glycosaminoglycan such as hyaluronic acid, and their use for treating diseases, particularly musculoskeletal diseases.
    Type: Application
    Filed: September 26, 2013
    Publication date: August 27, 2015
    Inventors: Enrico Bastianelli, Valentina Albarani
  • Human Bone-Forming Cells in the Treatment of Conditions and Bone Diseases Associated with Immunodeficiency or Immunosuppression
    Publication number: 20150164951
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of diseases and conditions associated with immunodeficiency or immunosuppression.
    Type: Application
    Filed: October 13, 2014
    Publication date: June 18, 2015
    Inventors: Valentina ALBARANI, Enrico BASTIANELLI, Cindy BADOER, Xavier PESESSE
  • Uses of Growth and Differentiation Factor 8 (GDF-8)
    Publication number: 20140286916
    Abstract: The present invention relates to uses of growth and differentiation factor 8 (GDF-8) in vitro or in vivo for reducing the immunogenicity or risk of rejection of cells such as in particular mesenchymal stem cells (MSC), tissues or materials. The present invention further relates to methods for differentiating MSC in vitro or ex vivo into osteoprogenitors or osteoblastic cells or a cell population comprising osteoprogenitors and/or osteoblastic cells using FGF-2 and GDF-8. In addition, the present invention relates to osteoprogenitors or osteoblastic cells or a cell population comprising osteoprogenitors and/or osteoblastic cells obtainable by such methods and to the osteoprogenitors or osteoblastic cells or a cell population comprising osteoprogenitors and/or osteoblastic cells for use in the treatment of musculoskeletal diseases.
    Type: Application
    Filed: October 10, 2012
    Publication date: September 25, 2014
    Applicant: Bone Therapeutics
    Inventors: Valentina Albarani, Enrico Bastianelli, Christelle Bizimungu, Alice Joly, Xuan Mai Nguyen, Isabelle Tytgat
  • TARGETS AND AGENTS FOR THE TREATMENT OF IMPAIRED BONE FRACTURE HEALING
    Publication number: 20140212380
    Abstract: The application teaches a composition comprising one or more pharmaceutical active ingredients selected from the group consisting of interleukin-8 (IL-8 or CXCL8), a functional fragment of IL-8, a functional variant of IL-8, and an agonist of IL-8 receptor, for therapeutic and/orprophylactic interventions in impaired bone fracture healing, such as but not limited to non-union fractures, mal-union fractures, or delayed union fractures.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 31, 2014
    Applicants: Universite Libre De Bruxelles, Centre Hospitalier Universitaire de Liege, Universite de Liege, Bone Therapeutics SA
    Inventors: Valerie Gangji, Jean-Philippe Hauzeur, Dominique De Seny, Myrielle Mathieu, Aude Ingels, Sabrina Rigutto, Delphine Spruyt, Enrico Bastianelli, Valentina Albarani, Xavier Pesesse, Michel Malaise
  • HUMAN BONE-FORMING CELLS IN THE TREATMENT OF CONDITIONS AND BONE DISEASES ASSOCIATED WITH IMMUNODEFICIENCY OR IMMUNOSUPPRESSION
    Publication number: 20110064692
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of diseases and conditions associated with immunodeficiency or immunosuppression.
    Type: Application
    Filed: May 8, 2009
    Publication date: March 17, 2011
    Applicant: BONE THERAPEUTICS S.A.
    Inventors: Valentina Albarani, Enrico Bastianelli, Cindy Badoer, Xavier Pesesse